Comparison Of US, EU Treaties Highlights Differences On ISP Liability 25/03/2013 by Intellectual Property Watch Leave a Comment Following the announcement that the United States and European Union will negotiate a free trade agreement, a comparison of recent US and EU treaties shows differences in their treatment of intellectual property.
Global Fund Receives USD 1.65B From US Congress; Names New Board Leadership 25/03/2013 by Intellectual Property Watch Leave a Comment The United States Congress on 21 March approved US$ 1.65 billion in aid and support for the Global Fund to Fight AIDS, Tuberculosis and Malaria, and US$ 4.07 billion for the US President’s Emergency Plan for AIDS Relief (PEPFAR). The Global Fund also announced a new Board chair and vice-chair.
Diverging Views On IPR Protection Needs In Africa Emerge At IP Workshop 25/03/2013 by Rachel Marusak Hermann, Intellectual Property Watch 1 Comment Dar es Salaam, Tanzania – Nigeria’s booming film industry, born in an intellectual property-free environment, was presented as a case study of how IP needs may vary depending on context during a recent workshop organised by the US Commerce Department. In parallel, representatives of multinational brands and law enforcement delivered a strong message on the gravity of counterfeit trade, highlighting its link to organised crime.
US Supreme Court To Hear Arguments On Pay-For-Delay Drug Deals 23/03/2013 by Catherine Saez, Intellectual Property Watch Leave a Comment The United States Supreme Court is scheduled to hear oral arguments on Monday in a case in which the US Federal Trade Commission is questioning payments made by brand name pharmaceutical companies to generic producers for delayed entry into the market of lower priced generics.
Conference Addresses Current Issues For Corporate IP Counsel 22/03/2013 by William New and Kelly Burke for Intellectual Property Watch Leave a Comment New York – A conference here this week aimed at corporate counsel for intellectual property addressed a range of issues of interest to that audience.
US Objective For EU-US FTA: Elevate IPR Enforcement 21/03/2013 by Intellectual Property Watch 1 Comment The Office of the United States Trade Representative (USTR) yesterday notified the US Congress of its intent to negotiate a free trade agreement with the European Union. And in case there was any doubt, among the negotiating objectives will be to raise the level of intellectual property rights protection and enforcement.
Global Pharma Companies See Battle For Survival In Pakistan 21/03/2013 by Shahzada Irfan Ahmed for Intellectual Property Watch 3 Comments Lahore, Pakistan – Weak regulation of the local pharmaceutical industry in Pakistan, including non-enforcement of intellectual property rights and the absence of a simple and swift dispute resolution mechanism, have hit the country’s health sector badly, industry sources say.
At US-Led Workshop, African Stakeholders Call For “Home Grown IP Agenda” 20/03/2013 by Rachel Marusak Hermann, Intellectual Property Watch Leave a Comment Dar es Salaam, Tanzania – In a re-cast, smaller version of the event that was planned and postponed last year, the US State Department’s workshop on IP utilisation and protection in Africa opened yesterday. It is co-organised by the African Intellectual Property Group (AIPG), a new pro-IP association of stakeholders across the continent, which says it’s time for Africa find its own voice on intellectual property issues.
Pharma, International Red Cross Combine To Fight NCDs 19/03/2013 by Intellectual Property Watch Leave a Comment The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and the International Federation of Red Cross and Red Crescent Societies (IFRC) announced on 19 March a two-year partnership on non-communicable diseases.
WIPO Reports Robust Growth In Demand For IP Rights In 2012 19/03/2013 by Tiphaine Nunzia Caulier for Intellectual Property Watch 1 Comment In a press briefing at the United Nations today, World Intellectual Property Organization Director General Francis Gurry described what he qualified as a robust growth in applications for patents, designs and trademarks despite the economic climate.